Just a clarification: Copaxone is protected by 4 formulation patents listed in the FDA's Orange Book expiring in 2014 (not composition of matter patent). Its H-W and Orphan Drug exclusivities expired 2001 and 2003 respectively.
Market Data 
Markets 
AI
